Physician profile
Lee Ocuin
NPI 1770769705
$1,668.54
in general payments reported to CMS, 2019-2025
13 companies · $1,061 in 2025
The $1,061 reported for 2025 was more than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.28 · 2020: $164 · 2022: $232 · 2023: $200 · 2025: $1,061.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $649 · Food and Beverage: $611.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $648.97 |
| Food and Beverage | $611.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Histosonics, INC. | $648.97 | 2025 | |
| Integra Lifesciences Corporation | $202.18 | 2023-2025 | Codman Certas, Codman Hakim, Cusa Clarity |
| Tela Bio, INC. | $167.94 | 2022 | |
| Biom'Up France Sas | $164.43 | 2020 | |
| Aroa Biosurgery Incorporated | $137.09 | 2023 | |
| Boston Scientific Corporation | $135.89 | 2025 | General - Therapies |
| Intera Oncology, INC | $118.67 | 2025 | Intera |
| Pharmacyclics LLC, An Abbvie Company | $25.69 | 2022 | |
| Incyte Corporation | $17.47 | 2023 | Pemazyre |
| Kerecis Limited | $14.35 | 2022 | |
| Baxter Healthcare | $12.28 | 2019 | |
| Ethicon US, LLC | $11.85 | 2022 | |
| Conmed Corporation | $11.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lee Ocuin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.